Analysis on the Utilization Situation of Antidiabetic Drugs in Different Medical Institutions of Shanghai Based on Drug Purchasing Database

杨燕,吴文辉,汤庆伟,王燕芳,胡玲玲,何江江

DOI: https://doi.org/10.7664/CHE20170314

2017-01-01

Abstract:Objective:To analyze the current situation of drug use of patients with diabetes in Shanghai,and evaluate the drug use rationality among all levels of medical institutions.Methods:Using the indicators of defined daily doses(DDDs) and defined daily consumption(DDDc) recommended by the World Health Organization(WHO),it conducted statistical analysis on the amount,price,dose of the antidiabetic drugs purchased from November 2013 to October 2014 in the Pharmaceutical Bidding Database of Shanghai.Results:The research on the top drug composition showed that the DDDs in different medical institutions of Shanghai was sulfonylureas(53.84％),followed by insulin and metformin.The analysis of the purchase amount shows that,the amount of antidiabetic drugs purchased by the primary,secondary and tertiary medical institutions were 573 million,322 million and 339 million respectively.Additionally,it sorted the DDDs by generic name and found the most frequently used antidiabetic drugs were gliclazide,glimepiride and recombinant human insulin,etc.The average level of medical institutions consistency for antidiabetic drug was 68.69％.Conclusion:Patients with diabetes primarily purchased the drug prescribed in the community health centers in Shanghai,DDDc was rational.Sulfonylureas,insulin and metformin were the most frequently used antidiabetic drugs,while sulfonylureas was used more frequently.It was closed in the primary and secondary medical institutions.